{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:40:54Z","timestamp":1792741254110,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T00:00:00Z","timestamp":1490572800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.vaccine.2017.03.071","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T20:35:47Z","timestamp":1491338147000},"page":"2531-2542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study"],"prefix":"10.1016","volume":"35","author":[{"given":"Aderonke","family":"Odutola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin O.C.","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra O.","family":"Ogundare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yauba","family":"Saidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer","family":"Foster-Nyarko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick K.","family":"Owiafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Ceesay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archibald","family":"Worwui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubukola T.","family":"Idoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olumuyiwa","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulie","family":"Bojang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheikh","family":"Jarju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isatou","family":"Drammeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Alderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Traskine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Devos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Schoonbroodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristien","family":"Swinnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Verlant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Dobbelaere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Borys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.071_b0005","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper \u2013 2012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2017.03.071_b0010","doi-asserted-by":"crossref","first-page":"394368","DOI":"10.1155\/2015\/394368","article-title":"Nasopharyngeal bacterial carriage in the conjugate vaccine era with a focus on pneumococci","volume":"2015","author":"Devine","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2017.03.071_b0015","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.vaccine.2016.03.107","article-title":"Status of research and development of pediatric vaccines for Streptococcus pneumoniae","volume":"34","author":"Alderson","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0020","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1016\/j.vaccine.2015.11.012","article-title":"Effect on nasopharyngeal pneumococcal carriage of replacing PCV7 with PCV13 in the Expanded Programme of Immunization in The Gambia","volume":"33","author":"Roca","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1473-3099(16)00054-2","article-title":"Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study","volume":"16","author":"Mackenzie","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.071_b0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0035","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.03.071_b0040","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1016\/j.vaccine.2012.10.076","article-title":"Safety and immunogenicity of pneumococcal protein vaccine candidates: monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA-pneumococcal histidine triad protein D vaccine","volume":"30","author":"Bologa","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0045","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2012.11.005","article-title":"Safety and immunogenicity of the pneumococcal pneumolysin derivative PlyD1 in a single-antigen protein vaccine candidate in adults","volume":"31","author":"Kamtchoua","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0050","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1016\/j.vaccine.2015.06.078","article-title":"Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: a phase I randomized controlled study","volume":"33","author":"Brooks","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0055","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1016\/j.vaccine.2014.02.052","article-title":"Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I\/II randomized clinical study","volume":"32","author":"Leroux-Roels","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0060","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.vaccine.2014.03.066","article-title":"Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial","volume":"32","author":"Prymula","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0065","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/21645515.2015.1111496","article-title":"Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2\u20134 years: a phase II randomized study","volume":"12","author":"Odutola","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.03.071_b0070","unstructured":"Skoberne M, Ferreira DM, Gritzfeld JF, Wright A, Collins A, Siddall N, et al. GEN-004 is safe, immunogenic and reduces acquisition of colonization in experimental human pneumococcal challenge model. In: Poster presented at the 10th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD). Glasgow, UK. 26\u201330 June 2016."},{"key":"10.1016\/j.vaccine.2017.03.071_b0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2249.2004.02611.x","article-title":"The role of pneumolysin in pneumococcal pneumonia and meningitis","volume":"138","author":"Hirst","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2017.03.071_b0080","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tim.2012.06.004","article-title":"Polyhistidine triad proteins of pathogenic streptococci","volume":"20","author":"Plumptre","year":"2012","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2017.03.071_b0085","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/IAI.69.2.949-958.2001","article-title":"Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis","volume":"69","author":"Adamou","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.071_b0090","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.vaccine.2011.01.085","article-title":"Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides","volume":"29","author":"Deno\u00ebl","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0095","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1128\/IAI.72.8.4534-4540.2004","article-title":"Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin","volume":"72","author":"Garcia-Su\u00e1rez","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.071_b0100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1096\/fj.08-119537","article-title":"Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H","volume":"23","author":"Ogunniyi","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2017.03.071_b0105","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1016\/j.vaccine.2011.05.051","article-title":"A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae","volume":"29","author":"Deno\u00ebl","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0110","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1128\/IAI.00378-10","article-title":"Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens","volume":"79","author":"Godfroid","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.071_b0115","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/21645515.2016.1234553","article-title":"Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen","volume":"13","author":"Hermand","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.03.071_b0120","doi-asserted-by":"crossref","first-page":"e75558","DOI":"10.1371\/journal.pone.0075558","article-title":"Comparison of the prevalence of common bacterial pathogens in the oropharynx and nasopharynx of Gambian infants","volume":"8","author":"Odutola","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.071_b0125","unstructured":"Prymula R, Szenborn L, Silfverdal SA, Wysocki J, Albrecht P, Fran\u00e7ois N, et al. Immunogenicity of primary vaccination with an investigational protein-based pneumococcal vaccine in infants in Europe: a phase II randomized trial. pneumonia 2014;3:92\u20133 (abstr ISPPD-0551)."},{"key":"10.1016\/j.vaccine.2017.03.071_b0130","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1128\/CVI.00050-09","article-title":"Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage","volume":"16","author":"Holmlund","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.03.071_b0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vaccine.2005.07.055","article-title":"Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage","volume":"24","author":"Holmlund","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0140","unstructured":"Chang L, Brooks WA, de Bruyn G, Bologa M, Hopfer R, Kirby D, et al. A multi-component pneumococcal protein vaccine is safe and immunogenic in a phase 1 randomized, placebo-controlled study. In: Oral presentation at the 9th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD). Hyderabad, India. 9\u201313 March 2014."},{"key":"10.1016\/j.vaccine.2017.03.071_b0145","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1128\/iai.62.12.5683-5688.1994","article-title":"Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae","volume":"62","author":"Alexander","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.071_b0150","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/IAI.02124-14","article-title":"Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae","volume":"82","author":"Kaur","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.03.071_b0155","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.4161\/21645515.2014.979631","article-title":"The host immune dynamics of pneumococcal colonization: implications for novel vaccine development","volume":"10","author":"Khan","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2017.03.071_b0160","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/j.vaccine.2010.03.030","article-title":"A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination","volume":"28","author":"Van Effelterre","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.071_b0165","doi-asserted-by":"crossref","first-page":"e1004339","DOI":"10.1371\/journal.ppat.1004339","article-title":"TLR2 signaling decreases transmission of Streptococcus pneumoniae by limiting bacterial shedding in an infant mouse Influenza A co-infection model","volume":"10","author":"Richard","year":"2014","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730405X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1730405X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:22:53Z","timestamp":1759400573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1730405X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":33,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0264410X1730405X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.071","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}